Our aim is to revolutionize the women’s health market
We have developed a unique concept in the field of smart therapies and diagnostics which has the potential to revolutionize the women’s health market.
FOUNDER, CEO and CTO
Willem de Laat MD PhD MBA
Willem is the visionary father of LiGalli and acts as CEO and CTO of the company. His responsibilities are product development, partnerships and external communication.
CFO and COO
Frédérique Steels MSc MBA
Bringing extensive experience in corporate finance, her responsibilities at LiGalli are finance, legal & tax and leading the fundraising efforts. She will also play a role in the negotiation of partnerships.
Director Pharma and Technology
Victor Nickolson PhD
Victor has researched many different molecules in his career and developed many new medications. He has a broad interest in the pharmaceutical market, also in technical aspects of medical devices and diagnostic principles.
Director Clinical and Sensoring
Maarten Wiegerinck MD PhD
The creative mind of the company, Maarten has developed innovative devices and has always believed in the diagnostical potential of the mucosal wall, ever since he his thesis work which covered the topic.
Project Manager LiGalli MedRing
Martin Walraven MSc Pharmacist
He is an experienced Project Manager.Spent his whole life working for various top 20 ranking International pharmaceutical companies, bringing innovative products from Research to commercialisation
Business Development Manager
Barry van Amsterdam MSc
Barry has developed an innovative new valuation model as certified valuation manager and implemented it in the business case of LiGalli's lead compound.